| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/10/1999 | CA2317502A1 Matrix metalloproteinase inhibitors |
| 09/10/1999 | CA2264970A1 Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
| 09/10/1999 | CA2263392A1 Ipriflavone preparation process |
| 09/10/1999 | CA2249661A1 Novel compounds |
| 09/10/1999 | CA2249041A1 Novel compounds |
| 09/09/1999 | DE19809845A1 S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen For their preparation and compositions containing these compounds S-11beta-substituted benzaldoxime-estra-4,9-dien-kohlensäurethiolester, procedures pharmaceutical preparations |
| 09/09/1999 | DE19809635A1 Verfahren zur Darstellung von Endothelinrezeptorantagonisten vom Sulfanyltyp A process for the preparation of endothelin receptor antagonists of Sulfanyltyp |
| 09/09/1999 | DE19809304A1 Formulierungen mit antiviraler Wirkung Formulations having antiviral activity |
| 09/09/1999 | DE19809242A1 Verfahren zur Herstellung von festen, sphärischen Formkörpern, enthaltend pharmazeutische Wirkstoffe in einer Bindemittelmatrix A process for the preparation of solid, spherical moldings containing pharmaceutical active ingredients in a binder matrix |
| 09/09/1999 | DE19809144A1 Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten New asymmetrically substituted carboxylic acid derivatives, their preparation and use as a mixed ET¶LAMBDA¶ / ET¶B¶ receptor antagonists |
| 09/09/1999 | DE19808889A1 Vektoren und Viren zur Gentherapie Vectors and viruses for gene therapy |
| 09/09/1999 | DE19806946A1 Combination of (acyl) carnitine and retinoid for use in skin care, effective e.g. against light-induced damage and inflammation |
| 09/08/1999 | EP0940410A1 Novel heparin-like sulfated polysaccharides |
| 09/08/1999 | EP0940401A1 2-carbonylthiazole derivatives and use of the same |
| 09/08/1999 | EP0940400A1 Novel heterocyclic amide compounds and medicinal uses thereof |
| 09/08/1999 | EP0940391A2 Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 09/08/1999 | EP0940386A1 Benzocyclobutan compounds, their process for preparation and pharmaceutical compositions containing them |
| 09/08/1999 | EP0940143A2 Use of PKC-inhibitors for the manufacture of a medicament for the treatment of asthma |
| 09/08/1999 | EP0940142A2 Use of PKC inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases |
| 09/08/1999 | EP0940141A2 Use of PKC inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection |
| 09/08/1999 | EP0940140A1 Topical composition of alpha hydroxy acids and ceramides for the treatment of skin conditions |
| 09/08/1999 | EP0940139A2 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
| 09/08/1999 | EP0939829A1 Methods of modulating melanin synthesis |
| 09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939819A1 Mini-e1a genes and gene products |
| 09/08/1999 | EP0939812A2 Novel human macrophage antigen |
| 09/08/1999 | EP0939807A2 Secreted proteins and polynucleotides encoding them |
| 09/08/1999 | EP0939802A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 09/08/1999 | EP0939766A2 Synthesis of soluble beta-sheet forming peptides |
| 09/08/1999 | EP0939760A2 1-thiogalactose derivatives |
| 09/08/1999 | EP0939759A2 Saccharide derivatives |
| 09/08/1999 | EP0939758A1 HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS |
| 09/08/1999 | EP0939757A1 Novel integrin receptor antagonists |
| 09/08/1999 | EP0939754A2 N-oxy-naphthalimides as antibacterial agents |
| 09/08/1999 | EP0939751A1 Macrophage lipid chemoattractant |
| 09/08/1999 | EP0939659A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 09/08/1999 | EP0939656A1 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 09/08/1999 | EP0939655A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 09/08/1999 | EP0939654A1 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 09/08/1999 | EP0939653A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/08/1999 | EP0939646A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/08/1999 | EP0939644A1 Enhanced stimulation of erythropoiesis |
| 09/08/1999 | EP0939643A1 Immunomodulating compounds comprising d-isomers of amino acids |
| 09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 09/08/1999 | EP0939640A1 Improvements in polymer compositions for chemotherapy and methods of treatment using the same |
| 09/08/1999 | EP0939639A1 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 09/08/1999 | EP0939638A1 Injectable formulations of avermectins and milbemycins |
| 09/08/1999 | EP0939637A1 Method of treating sinusitis with uridine triphosphates and related compounds |
| 09/08/1999 | EP0939636A1 Application of thalidomide to the treatment of parkinson's disease and parkisonian syndromes |
| 09/08/1999 | EP0939635A1 Improved intraocular irrigating solution containing a polyamine antagonist |
| 09/08/1999 | EP0939634A1 Il-8 receptor antagonists |
| 09/08/1999 | EP0939633A1 Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 09/08/1999 | EP0939631A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 09/08/1999 | EP0939630A1 Use of benzopyranols to treat neurological disorders |
| 09/08/1999 | EP0939629A1 Thiol sulfonamide metalloprotease inhibitors |
| 09/08/1999 | EP0939628A1 Thiol sulfone metalloprotease inhibitors |
| 09/08/1999 | EP0939627A1 Pentafluorobenzenesulfonamides and analogs |
| 09/08/1999 | EP0939626A1 Galenic formula with extended release of milnacipran |
| 09/08/1999 | EP0939625A1 2-cyclopenten-1-one as an inducer of hsp70 |
| 09/08/1999 | EP0939624A1 Effervescent bisphosphonate formulation |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0939621A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 09/08/1999 | EP0939619A1 Detergent cosmetic compositions and use thereof |
| 09/08/1999 | EP0799205B1 1,4,4-(trisubstituted)cyclohex-1-ene derivatives as pde iv- and tnf-inhibitors |
| 09/08/1999 | EP0791004B1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 09/08/1999 | EP0790981B1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| 09/08/1999 | EP0769026B1 Fractionated polydisperse compositions |
| 09/08/1999 | EP0749415B1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors |
| 09/08/1999 | EP0730594B1 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES |
| 09/08/1999 | EP0706393B1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 09/08/1999 | EP0670713B1 A pharmaceutical formulation |
| 09/08/1999 | EP0592643B1 Pleuromutilin derivatives |
| 09/08/1999 | EP0589874B1 Use of (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid for the preparation of a longlasting antidiabetic medicament |
| 09/08/1999 | CN1228092A Purine derivatives and their use as anti-coagulants |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1228090A Naphthyridines with affect IL-4 and G-CSF |
| 09/08/1999 | CN1228088A Arylsulfonylimidazolone derivatives as antimumor agent |
| 09/08/1999 | CN1228087A Substituted pyrimidine derivatives and their pharmaceutical use |
| 09/08/1999 | CN1228085A New polycyclic 2,3-phthalazine derivatives and their use |
| 09/08/1999 | CN1228083A Arylsulfonylamino hydroxamic acid derivatives |
| 09/08/1999 | CN1228080A Novel immunotherapeutic agents and their use in production of cytokine levels |
| 09/08/1999 | CN1228028A Use of histamine for therapeutic purposes |
| 09/08/1999 | CN1228026A Combinations comprising VX 478, zidovudine, FTC and/or 3TC for use in treatment of HIV |
| 09/08/1999 | CN1228025A Hydrosterol composition and use thereof |
| 09/08/1999 | CN1228024A Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/08/1999 | CN1228023A Orally applicable formulation of quinolone or naphthyridone carboxylic acids |
| 09/08/1999 | CN1228022A Parenteral paclitaxel stable non-toxic formulation |
| 09/08/1999 | CN1228020A Multi-layered osmotic device |
| 09/08/1999 | CN1228018A Liposomal compositions and method of using them |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/08/1999 | CN1227842A Penems and their derivatives |
| 09/08/1999 | CN1227841A Piperazine derivatives as 5-HT1A antagonists |
| 09/08/1999 | CN1227747A Nucleic acid hypoglycemic mixture |
| 09/08/1999 | CN1227743A Trovafloxacin mesylate tablet |
| 09/08/1999 | CN1045005C Bisoxadiazolidine derivative, medicinal composition containing same and use thereof |
| 09/07/1999 | US5948933 Tropane analogs and methods for inhibition of monoamine transport |
| 09/07/1999 | US5948918 Plant extracts |
| 09/07/1999 | US5948913 Hydrate for drug use |
| 09/07/1999 | US5948902 Antisense oligonucleotides to human serine/threonine protein phosphatase genes |